Lexology January 30, 2023
Ropes & Gray LLP

Our handling of, and emergence from, the COVID-19 pandemic has, in no small part, been due to the many significant advances made by big tech and the life sciences sector.

For example, big tech facilitated contract-tracing and the roll-out of electronic vaccine records, the medical device sector significantly scaled-up production of much-needed ventilators and big pharma developed vaccines and treatments for the longer term.

Unsurprisingly, some of the practices that were still in their infancy before the pandemic are now commonplace: the rise of telemedicine being one such example. However, 2023 looks set to be the year that life sciences companies push even further into the domain of big tech.

In the early days of the industry, medical devices elicited...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Medical Devices, Technology, Wearables
Guardant posts data for colon cancer blood test amid push from rivals
Intuitive details launch plan for new da Vinci 5 robot
6 ways the FDA can improve medical device recalls
FDA gets granular with draft medical device premarket approval update
The health and wealth at Med-Tech Innovation Expo

Share This Article